Medix Biochemica Takes Over Molecular Diagnostics Raw Materials Manufacturing Firm

Business Acquisition Medix Biochemica Takes Over Molecular Diagnostics Raw Materials Manufacturing Firm

03.02.2022Source: Press release

Medix Biochemica has acquired the Germany-based manufacturer of innovative and high-quality raw materials in molecular diagnostics – Mypols Biotec. The move is in line with the company’s aim of expanding its reagent offerings for molecular diagnostics as well as supports the firm’s portfolio of in vitro diagnostics raw materials.

Mypols Biotec molecular diagnostics labs in Konstanz, Germany.
(Source: Mypols Biotec)

Espoo/Finland – Medix Biochemica, a global leader in critical IVD raw materials, has acquired 100 percent of the shares of Mypols Biotec. As a result of the acquisition, Medix Biochemica broadens its portfolio of molecular diagnostic raw materials for the in vitro diagnostics (IVD) industry, complements its scientific expertise and strengthens its local presence in Western Europe. Mypols Biotec will form a significant part of the newly established Molecular Diagnostics Business Unit within Medix Biochemica Group, and its high-quality operations will continue in Konstanz, Germany. All founders of the company will remain involved in the business following the acquisition.

“This acquisition is a great step towards our vision to be the first-choice, independent raw material partner for the IVD industry, and it further accelerates Medix Biochemica’s growth in molecular diagnostics reagents business which is a key strategic expansion area for us. The broad portfolio of Mypols Biotec, including unique and innovative molecular diagnostics reagents, complements Medix Biochemica’s existing molecular diagnostics offering. With Mypols technology, we enable customers to shorten their assay development time and complexity, and perform molecular testing directly from crude samples. We will offer more flexibility in assay development by partnering in custom development projects. We are excited about the opportunity to offer these molecular diagnostics products to our global customer base,” says Steve Ferguson, CEO of Medix Biochemica.

Unfold for details of your consent

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:47974828)

Business Acquisition Medix Biochemica Takes Over Molecular Diagnostics Raw Materials Manufacturing Firm

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Consent to the use of data for promotional purposes